08/04/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 8/4/2020. Differences in mortality between groups of people and countries are important proxy indicators of relative risk of death that guide policy decisions regarding scarce medical resource allocation during the ongoing COVID-19 pandemic. This four-page document is intended to help countries estimate case fatality ratio (CFR), and, if possible, infection fatality ratio (IFR), as appropriately and accurately as possible, while accounting for possible biases in their estimation. (PDF)
08/03/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/3/2020. The information on this web page is provided to assist emergency planners who may need to consider local conditions, statutory authorities, resources, agreements, and other critical factors to form the final plan for disaster sheltering of household pets, service animals, and support animals during the COVID-19 pandemic. (Text)
08/03/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 8/3/2020. As the COVID-19 pandemic progresses, Congress may consider whether and how to guide U.S. contact tracing efforts. This three-page document discusses COVID-19-specific aspects of contact tracing, and issues for Congress to consider. (PDF)
08/01/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 8/1/2020. This report summarizes the fourth meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the coronavirus disease (COVID-19), which took place on July 31, 2020. Recommendations for state parties include sharing best practices, including from intra-action reviews, with WHO; and applying lessons learned from countries that are successfully re-opening their societies (including businesses, schools, and other services) and mitigating resurgence of COVID-19. (Text)
07/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Atellica® IM SARS-CoV-2 IgG (COV2G) assay. The Atellica® IM SARS-CoV-2 IgG (COV2G) assay is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (potassium EDTA and lithium heparin). (PDF)
07/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ADVIA Centaur® SARS-CoV-2 IgG (COV2G) assay. The ADVIA Centaur® SARS-CoV-2 IgG (COV2G) assay is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (potassium EDTA and lithium heparin). (PDF)
07/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/31/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 Test Kit (Real-time PCR). The SARS-CoV-2 Test Kit (Real-time PCR) is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/31/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/31/2020. This eight-page letter details the Emergency Use Authorization (EUA) for the UCSD RC SARS-CoV-2 Assay for qualitative detection of nucleic acid from SARS-CoV-2 in clinician-instructed self-collected nasal swab specimens (collected on site), and clinician-collected upper respiratory specimens (nasopharyngeal, mid-turbinate, anterior nares or oropharyngeal swab specimens) collected from individuals suspected of COVID-19 by their healthcare provider. This test is also for the qualitative detection of nucleic acid from the SARS-CoV-2 in pooled samples. (PDF)
07/30/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/30/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CRL Rapid Response test that has been authorized for emergency use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/24/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 7/24/2020. This 49-minute webinar describes strategies used for testing COVID-19 patients requiring surgical procedures, and reviews the approach at the University of Nebraska Medical Center and Emory University on virus transmission and personal protective equipment use for infection control. It also defines the setup and pre-briefing process for surgeries during COVID-19, and reviews physical infrastructure setup in alignment with engineering controls in an intraoperative, and post-anesthesia care unit setting. (Video or Multimedia)
07/22/2020 12:00 AM EDT
Source: Alliance for Child Protection in Humanitarian Action. Published: 7/22/2020. This web page provides links to a webinar series about protection of children during the COVID-19 pandemic. Some webinars are available in French, Portuguese, and Spanish. (Video or Multimedia)
07/17/2020 12:00 AM EDT
Source: National Emerging Special Pathogens Training and Education Center (NETEC). Published: 7/17/2020. This 53-minute webinar describes strategies used for testing COVID-19 patients requiring surgical procedures, and reviews the approach at the University of Nebraska Medical Center and Emory University on virus transmission and personal protective equipment (PPE) use for infection control. It also defines the setup and pre-briefing process for surgeries during COVID-19, and reviews physical infrastructure setup in alignment with engineering controls in an intraoperative, and post-anesthesia care unit setting. (Video or Multimedia)
07/07/2020 12:00 AM EDT
Source: Congressional Research Service [Library of Congress] (CRS). Published: 7/7/2020. Congress and the Administration have initiated changes to behavioral health services in recognition of the need to continue treatment during the COVID-19 pandemic. This four-page report discusses those changes, and issues for Congress to consider. (PDF)
07/01/2020 12:00 AM EDT
Source: Canadian Foundation for Healthcare Improvement (CFHI). Published: 7/2020. This 20-page report is intended to be helpful to provincial/territorial health authorities and medical officers of health who are developing and implementing guidance regarding family caregivers as essential partners in care during the COVID-19 pandemic. (PDF)
07/01/2020 12:00 AM EDT
Source: Canadian Foundation for Healthcare Improvement (CFHI). Published: 7/2020. This 38-page report focuses on promising practices in six key areas that have the potential to reduce the risk of future COVID-19 outbreaks or mitigate their effects in the long-term care (LTC) and retirement home sector: preparation; prevention; people in the workforce; pandemic response and surge capacity; planning for COVID-19 and non-COVID-19 care; and presence of family. (PDF)
06/19/2020 12:00 AM EDT
Source: Infectious Diseases Society of America (IDSA). Published: 6/19/2020. The information in this 13-page document provides federal, state, and local leaders a critical opportunity to prepare for an upcoming wave of COVID-19 infections to ensure a successful response that minimizes the numbers of new infections, hospitalizations, and deaths. (PDF)
05/06/2020 12:00 AM EDT
Source: Infectious Diseases Society of America (IDSA). Published: 5/6/2020. This web page provides an evidence-based diagnostic guideline to assists clinicians, clinical laboratorians, patients, and policymakers in decisions related to the optimal use of SARS-CoV-2 nucleic acid amplification tests. It provides a conceptual framework for understanding molecular diagnostic test performance, discusses the nuance of test result interpretation in a variety of practice settings, and highlights important unmet research needs in the COVID-19 diagnostic testing space. (Text)
05/01/2020 12:00 AM EDT
Source: Emory Healthcare. Published: 5/2020. Emory Healthcare's physicians and clinicians developed the protocols and resources on this web page to inform and share with other medical professionals during the COVID-19 pandemic. (Text)
05/01/2020 12:00 AM EDT
Source: Massachusetts General Hospital (MGH). Published: 5/2020. Massachusetts General Hospital is providing and curating this treatment guidance and information to help clinical professionals stay up-to-date during the COVID-19 crisis. (Text)
05/01/2020 12:00 AM EDT
Source: University of Nebraska Medical Center (UNMC). Published: 5/2020. Nebraska Medicine and the University of Nebraska Medical Center have provided these COVID-19 resources for healthcare providers, including information about personal protective equipment, special populations, and ambulatory treatment management. (Text)
05/01/2020 12:00 AM EDT
Source: American Academy of Family Physicians (AAFP). Published: 5/2020. This two-page document provides guidance for physicians who are considering re-opening their practices during the COVID-19 pandemic. Because re-opening nonessential businesses is a localized issue, the document provides factors for physicians to consider on resuming nonessential, in-person primary care. (PDF)
No hay comentarios:
Publicar un comentario